Close Menu

Given the nature of scientific discovery where findings can build on previous work, it's not illogical to think that sooner or later, researchers will "self-cite," says Bar-Ilan University graduate student Hadas Shema at the Scientific American Information Culture blog. But at the same time, self-citation is also considered "vanity, egotism, or an attempt in self-advertising," she adds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.